Pharmaceutical
ChemLinkedChemicalFoodCosmeticPharmaceuticalJapanAgrochemicalSustainability
News
Comprehensive coverage on the latest pharmaceutical regulatory update and industry activities in China.
INDUSTRY
Clinical Trial Cancer New Drug
Bispecific Antibody Becomes a Hotspot for Pharmaceutical Research in China In China, over 300 bispecific antibody (BsAb) drugs are being developed, among which nearly 100 have entered the clinical trial stage. By 2030, the Chinese BsAb market is expected to reach 10.8 billion USD.
Nov 25, 2022
INDUSTRY
Clinical Trial CRO
Top 10 CROs Using China's Human Genetic Resources in International Clinical Trials From Jan. to Oct. 2022, among the 3,632 international clinical trials approved by China to use the its human genetic resources outside China, about 52% are conducted by contract research organizations (CROs) and about 48% by the applicants themselves.
Nov 23, 2022
INDUSTRY
Marketing Approval Priority Review Innovative Drug Cancer Diabetes Drug Registration New Drug
Monthly Report: New Drug Approvals in China | October 2022 In October 2022, China NMPA approved 17 new drugs, including 11 chemical drugs and 6 biological products.
Nov 03, 2022
INDUSTRY
Innovative Drug Generic Drug Inhalation Respiratory Disease
China Inhalation Drug Market: Nearly 5 Billion USD in 2021 and Still Growing China is a huge inhalation drug market, whose value reached 35.48 billion yuan in 2021. The market shows two trends: 1. Though nebulizers take the highest market share, dry powder inhalers and metered-dose inhalers' shares are expected to increase. 2. Overseas inhalation drugs account for the most shares, while Chinese generics seek to improve shares via volume-based procurement.
Oct 17, 2022
INDUSTRY
Marketing Approval Priority Review Innovative Drug Generic Drug Biological Product Cancer Diabetes Drug Registration New Drug
Monthly Report: New Drug Approvals in China | September 2022 In September 2022, China NMPA approved 16 new drugs, including 12 chemical drugs and 4 biological products.
Oct 08, 2022
INDUSTRY
E-commerce
China Pharma Retail Market: Pharmacy Chains and E-commerce Are Growing In recent years, China’s retail pharmacies manifest two trends: (1) pharmacy chains expand to more stores and increase in market share; (2) e-commerce is growing faster than offline business.
Sep 28, 2022
INDUSTRY
Volume-based Procurement E-commerce
China's 2021 Medical Product Sales Exceed $360B According to the Ministry of Commerce, China's national sales of medical products in 2021 reached 2,606.4 billion yuan (367.71 billion USD), with a year-on-year (YoY) growth of 8.5%.
Sep 28, 2022
INDUSTRY
MAH Marketing Approval Priority Review Innovative Drug Generic Drug Biological Product Diabetes Rare Disease Drug Registration New Drug
Monthly Report: New Drug Approvals in China | August 2022 In August 2022, China NMPA approved 13 new drugs, including 9 chemical drugs and 4 biological products. Among them, MSD's HPV 9-valent vaccine got approval to expand the target group from females 16-26 years of age to 9-45 years of age.
Sep 09, 2022
INDUSTRY
Priority Review Innovative Drug Rare Disease Drug Registration New Drug
China CDE to Grant Priority Review Designation to Sanofi's Avaglucosidase Alfa, a Rare Disease Therapy Sanofi's avalglucosidase alfa entered the preliminary list of priority review designation on August 15, as shown on China CDE's website. If no objections are filed to CDE by August 22, the drug will officially be granted the priority review and can complete the technical review within 70 workdays, much shorter than 200 workdays for drugs without the priority review.
Aug 18, 2022
INDUSTRY
Biological Product New Drug
China's Growth Hormone Treatment Market Is Booming In 2018, China's growth hormone market size was 0.6 billion USD. With an estimated CAGR of 15.7% from 2018 to 2030, the market size is expected to reach 3.2 billion USD by 2030.
Aug 15, 2022
Pre 1... 34567 ...9 Next
Most Popular